implants genetically engineered skin cells dogs hemophilia b rare bleeding disorder blood clot properly bring symptoms control short periods according researchers salk institute la jolla although researchers many technical obstacles overcome new approach produce cure animals research reported monday prestigious proceedings national academy sciences represents bold new approach genetic disorder presently treated expensive protein isolated concentrated blood plasma this major step forward toward cure hemophilia said hematologist frederick rickles university connecticut school medicine i think terribly exciting hemophilia afflicts many 20000 males united states women carry gene disorder generally develop it caused defective gene would normally serve blueprint protein plays crucial role clotting process prevents people bleeding death cut wounded it exists two main forms called a b hemophilia a common form type associated european royalty caused defect protein called factor viii hemophilia b also known christmas disease surname first two people diagnosed caused defect protein called factor ix currently treatment either type injections either factor viii factor ix isolated blood healthy individuals because proteins present blood small quantities large volumes blood must pooled isolation procedure greatly increasing risk material contaminated viruses cause hepatitis aids an estimated 90 95 nations 7000 9000 hemophiliacs severe cases disease thought infected aids virus among moderate hemophiliacs require fewer injections infection rate thought 40 50 researchers developed techniques cleanse blood products viruses isolated protein expensive a years treatment may cost much $ 50000 as alternative collecting factor viii blood researchers produced laboratory using genetic engineering techniques this product successfully tested humans us food drug administration approved marketing genetically engineered factor ix yet tested humans the new research reported monday opens door technique hemophiliacs would produce protein body the research conducted using dogs suffer hemophilia b they maintained unique colony university north carolina chapel hill pathologists marjorie s read kenneth m brinkhous called keagles animals arose cross cairn terrier beagle colony maintained 25 years salk institute molecular biologists jonathan h axelrod inder m verma took skin cells keagles used specially designed virus introduce healthy gene factor ix their paper reports cells produce secrete factor ix axelrod verma constructed miniorgans engineered cells implanted skin keagles the implant produces factor ix least weeks animals blood clot normally axelrod said but clotting time gets longer longer indicating failure implant so far said cant pinpoint specific problem it may cells dying stop producing factor ix the researchers trying isolate correct problem im discouraged said rickles vice president medical affairs national hemophilia foundation while may take time right track